Literature DB >> 16550354

Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo.

Mike P Wattjes1, Götz G Lutterbey, Michael Harzheim, Jürgen Gieseke, Frank Träber, Luisa Klotz, Thomas Klockgether, Hans H Schild.   

Abstract

The aims of this study were to determine and compare the sensitivity of T2 turbo spin-echo (T2 TSE) and fluid-attenuated inversion recovery (FLAIR) sequences at 3.0 T in the detection of inflammatory lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis. Forty-nine patients were examined with a 3.0 T MRI system using 5 mm axial sections of T2 TSE (2:19 min), FLAIR (4:00 min) and pre- and postcontrast T1 spin-echo sequences (3:37 min). Brain lesions were counted and categorized according to their anatomic location. Patients were classified according to Barkhof MRI criteria for FLAIR and T2 TSE sequences. The FLAIR sequence detected more lesions in every anatomic region except for the infratentorial region. The higher sensitivity was significant for the total number of lesions (p<0.01), the juxtacortical (p<0.01), and the periventricular (p=0.01) region. A 9% increase of infratentorial lesions using the T2 TSE sequence was not significant. The higher sensitivity using the FLAIR sequence resulted in one additional MRI criterion in nine patients, whereas the better detection of infratentorial lesions using the T2 TSE sequence resulted in additional MRI criteria in three patients. In conclusion, FLAIR provides the highest sensitivity when compared with the T2 TSE, although T2 TSE still has a diagnostic relevance in terms of MRI criteria classification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550354     DOI: 10.1007/s00330-005-0082-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials.

Authors:  M Filippi; J H van Waesberghe; M A Horsfield; S Bressi; C Gasperini; T A Yousry; M L Gawne-Cain; S P Morrissey; M A Rocca; F Barkhof; G J Lycklama à Nijeholt; S Bastianello; D H Miller
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2D CINE magnetic resonance imaging: comparison of 1.5 T vs. 3.0 T.

Authors:  Matthias Gutberlet; Kerstin Schwinge; Patrick Freyhardt; Birgit Spors; Matthias Grothoff; Timm Denecke; Lutz Lüdemann; Ralph Noeske; Thoralf Niendorf; Roland Felix
Journal:  Eur Radiol       Date:  2005-05-05       Impact factor: 5.315

3.  MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T.

Authors:  D H Lee; A D Vellet; M Eliasziw; L Vidito; G C Ebers; G P Rice; L Hewett; S Dunlavy
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

Review 4.  Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.

Authors:  Massimo Filippi; Andrea Falini; Douglas L Arnold; Franz Fazekas; Oded Gonen; Jack H Simon; Vincent Dousset; Mario Savoiardo; Jerry S Wolinsky
Journal:  J Magn Reson Imaging       Date:  2005-06       Impact factor: 4.813

5.  Comparison of MR pulse sequences in the detection of multiple sclerosis lesions.

Authors:  T A Yousry; M Filippi; C Becker; M A Horsfield; R Voltz
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

6.  Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease.

Authors:  G Lutterbey; J Gieseke; M von Falkenhausen; N Morakkabati; H Schild
Journal:  Eur Radiol       Date:  2004-11-23       Impact factor: 5.315

7.  Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.

Authors:  Arjan Minneboo; Frederick Barkhof; Chris H Polman; Bernard M J Uitdehaag; Dirk L Knol; Jonas A Castelijns
Journal:  Arch Neurol       Date:  2004-02

8.  Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla.

Authors:  Nancy L Sicotte; Rhonda R Voskuhl; Seth Bouvier; Rochelle Klutch; Mark S Cohen; John C Mazziotta
Journal:  Invest Radiol       Date:  2003-07       Impact factor: 6.016

9.  Disseminated lesions at presentation in patients with optic neuritis.

Authors:  I E Ormerod; W I McDonald; G H du Boulay; B E Kendall; I F Moseley; A M Halliday; R Kakigi; A Kriss; E Peringer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  12 in total

1.  Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T.

Authors:  Mike P Wattjes; Götz G Lutterbey; Michael Harzheim; Jürgen Gieseke; Frank Träber; Luisa Klotz; Thomas Klockgether; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-29       Impact factor: 5.315

Review 2.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 4.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

5.  Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.

Authors:  M P Wattjes; G G Lutterbey; J Gieseke; F Träber; L Klotz; S Schmidt; H H Schild
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

6.  Multiple sclerosis: identification of temporal changes in brain lesions with computer-assisted detection software.

Authors:  M Bilello; M Arkuszewski; P Nucifora; I Nasrallah; E R Melhem; L Cirillo; J Krejza
Journal:  Neuroradiol J       Date:  2013-05-10

7.  Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Stephan Schmidt; Hans H Schild; Frank Träber
Journal:  Neuroradiology       Date:  2007-11-03       Impact factor: 2.804

Review 8.  High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Neuroradiology       Date:  2009-03-11       Impact factor: 2.804

9.  Gadolinium enhancement of atherosclerotic plaque in the middle cerebral artery: relation to symptoms and degree of stenosis.

Authors:  C-W Ryu; G-H Jahng; H S Shin
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-10       Impact factor: 3.825

10.  Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla.

Authors:  Birgit Simon; Stephan Schmidt; Carsten Lukas; Jürgen Gieseke; Frank Träber; Dirk L Knol; Winfried A Willinek; Jeroen J G Geurts; Hans H Schild; Frederik Barkhof; Mike P Wattjes
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.